Roche receives FDA clearance for cobas® CT/NG for cobas® 6800/8800 Systems

PLEASANTON, Calif., April 16, 2018 /PRNewswire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has provided 510(k) clearance for cobas® CT/NG for use on the cobas® 6800/8800 Systems for the direct detection of Chlamydia trachomatis…

Share this post